Aquilo Capital Management, LLC Ngm Biopharmaceuticals Inc Transaction History

Aquilo Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$20.15 - $26.19 $24.1 Million - $31.3 Million	-1,194,237 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $1.05 Million - $2.1 Million	70,000 Added 6.23%	1,194,237 $23.6 Million
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $2.97 Million - $3.79 Million	118,703 Added 11.8%	1,124,237 $32.7 Million
Q4 2020 Feb 16, 2021	SELL	$16.21 - $31.44 $207,488 - $402,432	-12,800 Reduced 1.26%	1,005,534 $30.5 Million
Q3 2020 Nov 16, 2020	SELL	$15.59 - $19.97 $1.2 Million - $1.53 Million	-76,850 Reduced 7.02%	1,018,334 $16.2 Million
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $574,560 - $1.13 Million	48,000 Added 4.58%	1,095,184 $21.6 Million
Q1 2020 May 15, 2020	BUY	$10.0 - $19.51 $10.5 Million - $20.4 Million	1,047,184 New	1,047,184 $12.9 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aquilo Capital Management, LLC with notifications on news.